PortalPublikationenLoss of nuclear localized and tyrosine phosphorylated Stat5 ...

Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.

Links

  • Amy R Peck
  • Agnieszka K Witkiewicz
  • Chengbao Liu
  • Ginger A Stringer
  • Alexander C Klimowicz
  • Edward Pequignot
  • Boris Freydin
  • Thai H Tran
  • Ning Yang
  • Anne L Rosenberg
  • Jeffrey A Hooke
  • Albert J Kovatich
  • Marja T Nevalainen
  • Craig D Shriver
  • Terry Hyslop
  • Guido Sauter
  • David L Rimm
  • Anthony M Magliocco
  • Hallgeir Rui

Beteiligte Einrichtungen

Abstract

To investigate nuclear localized and tyrosine phosphorylated Stat5 (Nuc-pYStat5) as a marker of prognosis in node-negative breast cancer and as a predictor of response to antiestrogen therapy.

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer18
ISSN0732-183X
StatusVeröffentlicht - 2011
pubmed 21576635